Technical Analysis for PRFX - PainReform Ltd.

Grade Last Price % Change Price Change
F 0.45 -10.02% -0.05
PRFX closed down 10.02 percent on Friday, November 1, 2024, on 30 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 13
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -10.02%
New 52 Week Low Weakness -10.02%
Wide Bands Range Expansion -10.02%

   Recent Intraday Alerts

Alert Time
Down 10% about 20 hours ago
60 Minute Opening Range Breakdown about 23 hours ago
Down 5% about 23 hours ago
Down 3% 1 day ago
Rose Above Lower Bollinger Band 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug

Is PRFX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.16
52 Week Low 0.4318
Average Volume 480,627
200-Day Moving Average 5.25
50-Day Moving Average 0.85
20-Day Moving Average 0.63
10-Day Moving Average 0.63
Average True Range 0.10
RSI (14) 31.51
ADX 21.84
+DI 20.31
-DI 31.95
Chandelier Exit (Long, 3 ATRs) 0.58
Chandelier Exit (Short, 3 ATRs) 0.72
Upper Bollinger Bands 0.79
Lower Bollinger Band 0.47
Percent B (%b) -0.06
BandWidth 51.46
MACD Line -0.09
MACD Signal Line -0.09
MACD Histogram 0.0014
Fundamentals Value
Market Cap 911.61 Thousand
Num Shares 2.03 Million
EPS -6.64
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 0.00
Price-to-Book 0.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.55
Resistance 3 (R3) 0.56 0.53 0.54
Resistance 2 (R2) 0.53 0.50 0.53 0.53
Resistance 1 (R1) 0.49 0.49 0.47 0.48 0.52
Pivot Point 0.46 0.46 0.45 0.46 0.46
Support 1 (S1) 0.42 0.43 0.41 0.42 0.38
Support 2 (S2) 0.39 0.42 0.39 0.37
Support 3 (S3) 0.35 0.39 0.36
Support 4 (S4) 0.35